Meet Hugh Lokey who traveled 497 miles for more than 5 years for the treatment of thyroid cancer to MD Anderson. A 70 year Hugh benefited and survived from the thyroid cancer with the help of an effective medicine lenvakast 10mg Capsule. This medicine contains lenvatinib as an active ingredient which was tested and approved by the Food and Drug Administration (FDA) in February for the treatment of thyroid cancer.
Like Hugh, this medicine also has a long journey and every step in this journey was taken at MD Anderson. According to Hugh, his more than 5 year struggle tremendously worthwhile because of this medicine.
David Hong, M.D. began testing on a drug called E7080 (now called lenvatinib) in 2006 and found various types of tumor responded but response was particularly remarkable in thyroid cancer. In the phase III trial of this medicine, Hugh, a patient with thyroid cancer came to MD Anderson in 2010, and enrolled in the trial in 2012. Hugh said that his digestive system suffered because of the daily medication. However, tests confirmed his cancer had reduced after three months. Although the doctor reduced his dosage to manage stomach issues. Managing dosage to reduce side effects has become another benefit during the trial phase of this medicine.
New hope after decades with one treatment
Till now, patients with radioiodine-refractory thyroid cancer had only one treatment option which didn’t work for more than half the patients. According to clinical trials that were published in the New England Journal of Medicine, patients who are taking lenvatinib did not have any further growth of their tumors for 18.3 months as compared to the patient who got a placebo, this duration was 14.7 months longer.
Major achievement of the medicine is that 65% of people who took the drug responded. According to the Steven Sherman, M.D., chair of Endocrine Neoplasia and Hormonal Disorders and associate vice provost for Clinical Research overall response rate and treatment completion response with this medicine are very exciting and provide hope for further study in this area.
Hugh Lokey saying on his cancer treatment journey
Hugh says “”MD Anderson is different from any other hospital, so it’s been worth every mile” he also added in his statement that “Anytime I meet someone with cancer, the first thought I have is, ‘You should be at MD Anderson.”
Conclusion
Lenvakast 10mg Capsule (lenvatinib) has proven as a revolutionary medicine in the treatment of thyroid cancer. Varioud clinical trials strongly support the benefits and effectiveness in thyroid cancer patients. Like as we discussed above the case of Hugh Lokey who successfully fought his cancer with minimal side effects with the help of this medicine. Also, the drug has been approved by FDA, now everywhere patients can take the benefit of this medicine.
FAQs
Is lenvakast 10mg capsule really beneficial in the treatment of thyroid cancer?
A-Yes, many clinical trials, case studies, and research strongly suggest that this medicine is highly effective in the controlling progression of cancer and managing the condition better than pre existing treatment options.
Are there any side effects of this medicine?
A-Like any other anticancer medicine, this medicine also shows some adverse impact on the body during the treatment which they manage on their own.
Reference:
https://www.mdanderson.org/cancerwise/lenvatinib-brings-thyroid-cancer-patient-hope.h00-158988234.html
Leave a Reply